747071
Last Update Posted: 2012-08-28
Recruiting has ended
All Genders accepted | 18 Years + |
0 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Safety and Validation of Efficacy of Oral Administration of the Food Additive Colostrum Derived Anti Clostridium Difficile Antibodies
This clinical study is designed to evaluate the safety and efficacy of oral administration of the food additive colostrum derived antibodies to Clostridium difficile for prevention of Clostridium difficile associated disease (CDAD).
Eligibility
Relevant conditions:
Clostridium Difficile-Associated Diarrhea
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
Inclusion criteria
Exclusion criteria
locations
Data sourced from ClinicalTrials.gov